Incidence and Risk Factors of Hypomagnesemia in Head and Neck Cancer Patients Treated with Cetuximab

BACKGROUND: Hypomagnesemia is a common adverse event during cetuximab (Cmab) treatment. However, few reports have investigated the incidence and risk factors of hypomagnesemia in head and neck cancer patients treated with Cmab. METHODS: We retrospectively reviewed 131 head and neck cancer patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Enokida, Tomohiro, Suzuki, Shinya, Wakasugi, Tetsuro, Yamazaki, Tomoko, Okano, Susumu, Tahara, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021713/
https://www.ncbi.nlm.nih.gov/pubmed/27683640
http://dx.doi.org/10.3389/fonc.2016.00196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021713/
https://www.ncbi.nlm.nih.gov/pubmed/27683640
http://dx.doi.org/10.3389/fonc.2016.00196

Ejemplares similares